Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 26,700 shares at $54.21 ($1.4M) on 2020-02-24, disclosed to the SEC on 2020-02-26.
Open-market sale of $1.4M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.62 | 6,000 | $322K | 23.2% |
| 2 | $54.21 | 1,000 | $54K | 3.9% |
| 3 | $50.78 | 3,525 | $179K | 12.9% |
| 4 | $50.78 | 3,525 | $179K | 12.9% |
| 5 | $51.37 | 2,175 | $112K | 8.1% |
| 6 | $51.37 | 2,175 |
| $112K |
| 8.1% |
| 7 | $52.39 | 700 | $37K | 2.6% |
| 8 | $53.46 | 600 | $32K | 2.3% |
| 9 | $51.18 | 4,400 | $225K | 16.2% |
| 10 | $51.76 | 2,300 | $119K | 8.6% |
| 11 | $52.58 | 300 | $16K | 1.1% |
| Total | $51.92 avg | 26,700 | $1.4M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |